Navigation Links
WorldHeart Appoints New President and CEO
Date:2/6/2009

SALT LAKE CITY, Feb. 6 /PRNewswire-FirstCall/ -- World Heart Corporation ("WorldHeart", Nasdaq: WHRT), a pioneer in cardiac assist technologies, announced today that it has appointed John Alexander ("Alex") Martin as President and CEO. Mr. Martin also replaced Jal S. Jassawalla on the Board of Directors. Mr. Martin joins WorldHeart from Edwards Lifesciences where he was President of the North American Region and Corporate Vice President since 2004. Previously, Alex was with Cordis Corporation, a Johnson and Johnson (J&J) company, where he served as Senior Vice President of International and prior to that, Vice President of Sales and Marketing. At Cordis, he had responsibility for all U.S. coronary therapeutic and diagnostic device sales and under his leadership the company experienced significant growth and became the market leader. Alex was responsible for the launch of the first commercialized drug-eluting stent in the US while at Cordis.

Before Cordis, Mr. Martin, 55, served in sales, marketing and business development management positions at several organizations, including C.R. Bards' USCI division, Cambridge Heart and IMED Corporation. He also served as Director of the Emergency Medical Services at The Medical Center at Bowling Green. Mr. Martin earned a bachelor's degree from the University of Kentucky at Lexington.

Jal S. Jassawalla, WorldHeart's President and CEO since 2004 and co-founder of the original Novacor Medical Corporation, commented that, "I join WorldHeart's Board of Directors and employees in welcoming Alex to WorldHeart and the exciting and promising field of circulatory assist therapy." Mr. Jassawalla will continue in a senior role as Executive Vice President and Chief Technology Officer. His emphasis will be on research & development, product strategy, and clinical and regulatory affairs.

"We are pleased to have Alex Martin join WorldHeart," said Michael Estes, Chair of WorldHeart's Board of Directors. "Alex's extensive background in medical technologies and long-standing relationships within the cardiovascular community will be particularly valuable as WorldHeart brings its Levacor technology into the clinical arena and continues to advance its unique 'mag-lev' technology platform. The Board of Directors is also very pleased that Jal Jassawalla will continue in his key role as Executive Vice President of WorldHeart."

About World Heart Corporation

WorldHeart is a developer of mechanical circulatory support systems. WorldHeart is headquartered in Salt Lake City, Utah with additional facilities in Oakland, California, USA and Herkenbosch, The Netherlands. WorldHeart's registered office is in Ottawa, Ontario, Canada.

Any forward-looking statements in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and include all statements regarding WorldHeart's technology platform and reliance on key executives, as well as other statements that can be identified by the use of forward-looking language, such as "believes," "feels," "expects," "may," "will," "should," "seeks," "plans," "anticipates," or "intends" or the negative of those terms, or by discussions of strategy or intentions. Investors are cautioned that all forward-looking statements involve risk and uncertainties, including without limitation: WorldHeart's need for additional capital in the future; risks in product development and market acceptance of and demand for WorldHeart's products; delisting from the NASDAQ Stock Market if compliance with the listing standards is not regained; and other risks detailed in WorldHeart's filings with the U.S. Securities and Exchange Commission, including without limitation its Annual Report on Form 10-KSB/A for the year ended December 31, 2007 and its Quarterly Report on Form 10-Q/A for the quarter ended March 31, 2008 and its Quarterly Reports on Form 10-Q for the quarters ended June 30, 2008 and September 30, 2008.


'/>"/>
SOURCE World Heart Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. WorldHeart Submits IDE Application for a Pivotal Bridge-to-Transplant Study of the Levacor(TM) VAD
2. WorldHeart Regains Compliance With the Minimum Bid Price Rule
3. WorldHeart Receives Notice From the NASDAQ Stock Market Regarding Non-Compliance With Marketplace Rule 4310(c)(7)
4. WorldHeart Announces Effectiveness of Reverse Stock Split
5. WorldHeart Receives Favorable Decision to Continue NASDAQ Listing
6. WorldHeart Receives Non-Compliance Letter From NASDAQ Stock Market
7. WorldHeart Announces Voluntary Delisting from the Toronto Stock Exchange
8. WorldHeart Announces Possible Delisting Action by NASDAQ
9. WorldHeart Notified of TSX Delisting Review
10. WorldHeart Appoints David Pellone Chief Financial Officer
11. WuXi PharmaTech Appoints Stewart Hen and Ning Zhao to Its Board of Directors; Tao Lin Leaves Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... 31, 2016 , ... More than 80 representatives of the Hepatitis B ... Cancer Foundation held an event on National Hepatitis Testing Day outside of Philadelphia City ... the leading cause of liver cancer. , Foundation leaders and the citywide coalition they ...
(Date:5/31/2016)... ... May 31, 2016 , ... ... mix of advanced Artificial Intelligence (AI) and the latest in Clinical Patient ... center is integrating predictive analytic outputs directly into the clinical workflow. These insights ...
(Date:5/31/2016)... ... May 31, 2016 , ... Effective leaders not only drive service to the ... whole. On June 2, Northbound CEO Mike Neatherton and COO Paul Alexander will be ... opening plenary on “Leadership: The Journey to Authenticity” with Onsite Workshops CEO Miles Adcock ...
(Date:5/31/2016)... ... 31, 2016 , ... In his latest video, renowned AstroNumerologist ... humans. Using presidential candidate Donald Trump as an example, Kalsi describes the way ... not about adding numbers up,” says Kalsi. “It is about looking at each ...
(Date:5/31/2016)... ... 31, 2016 , ... TeaZa® Energy, LLC announces the launch of ... No Tobacco Day . The new flavor—Tropical TeaZa? Energy—will be available to customers ... , The new flavor is best described as a juicy, taste bud takeover. ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... , May 26, 2016 According ... "Medical Waste Management Market - U.S. Industry Analysis, Size, Share, ... management market in the U.S. was valued at US$ 5.89 ... CAGR of 3.4% from 2015 to 2023 to reach US$ ... analysis of current and emerging needle free drug delivery devices ...
(Date:5/26/2016)... , May 26, 2016 ... With Both Cost Savings and Overall Decreased ... (LSE: BTG), an international specialist healthcare company, has ... the 21st Annual Meeting of ISPOR (International Society ... of hepatocellular carcinoma (HCC) using yttrium-90 glass microspheres ...
(Date:5/26/2016)... Since its commercial introduction in ... life science tool for conducting genetic studies in a ... in its new report that the industry sits on ... by a range of new applications in the clinical ... http://photos.prnewswire.com/prnh/20140723/694805 ) , Since the Human ...
Breaking Medicine Technology: